Numb and NumbL inhibit melanoma tumor growth by influencing the immune microenvironment.

BMC Cancer

Department of Tumor and Immunology in Precision Medical Institute, The Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, 710000, P. R. China.

Published: November 2024

AI Article Synopsis

  • * Research involved analyzing immune signatures in SKCM patients and using conditional knockout mice to study the effects of Numb and NumbL on tumor immune profiles, revealing significant changes in immune cell types.
  • * The study concludes that Numb and NumbL can inhibit melanoma by influencing immune cell activity, suggesting they could be important targets for developing immunotherapy treatments for SKCM patients.

Article Abstract

Objective: Many investigation have sought to identify therapeutic targets and treatment strategies for skin cutaneous melanoma (SKCM). Numb, an endocytic adaptor protein, is known to act as a tumor suppressor in various human cancers. However, the roles of Numb and its homolog NumbL in immune microenvironment, and their effect on melanoma remain largely unexplored.

Methods: We analyzed the expression levels of Numb and NumbL, as well as immune signatures of SKCM patients by UCSCXenaShiny v1 database. We also constructed animal model using Numb and NumbL conditional knockout (cKO) mice. Distribution analysis of immune cells in tumors was performed by flow cytometry and pathology staining.

Results: Numb and NumbL were found to be consistently expressed at low levels in SKCM patients. In addition, alterations in tumor immune microenvironment were identified. The CD8 T, CD19 B, and NK1.1 CD49 cells were decreased in tumors of Numb and NumbL cKO mice, confirming previous bioinformatics analysis of immune signatures. Additionally, we observed CD68 macrophages to be increased as judged by tumor pathology staining.

Conclusion: Numb and NumbL were found to inhibit melanoma cell growth by modulating immune cell activity. These results suggested that Numb and NumbL may be potential therapeutic targets for SKCM patient immunotherapy.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11571900PMC
http://dx.doi.org/10.1186/s12885-024-13191-9DOI Listing

Publication Analysis

Top Keywords

numb numbl
28
immune microenvironment
12
numb
9
numbl inhibit
8
inhibit melanoma
8
therapeutic targets
8
immune signatures
8
skcm patients
8
cko mice
8
analysis immune
8

Similar Publications

Numb and NumbL inhibit melanoma tumor growth by influencing the immune microenvironment.

BMC Cancer

November 2024

Department of Tumor and Immunology in Precision Medical Institute, The Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, 710000, P. R. China.

Article Synopsis
  • * Research involved analyzing immune signatures in SKCM patients and using conditional knockout mice to study the effects of Numb and NumbL on tumor immune profiles, revealing significant changes in immune cell types.
  • * The study concludes that Numb and NumbL can inhibit melanoma by influencing immune cell activity, suggesting they could be important targets for developing immunotherapy treatments for SKCM patients.
View Article and Find Full Text PDF

Here, we investigated the mechanisms by which aging-related reductions of the levels of in skeletal muscle fibers contribute to loss of muscle strength and power, two critical features of sarcopenia. Numb is an adaptor protein best known for its critical roles in development, including asymmetric cell division, cell-type specification, and termination of intracellular signaling. expression is reduced in old humans and mice.

View Article and Find Full Text PDF

Comprehensive pan-cancer analysis of expression profiles and prognostic significance for NUMB and NUMBL in human tumors.

Medicine (Baltimore)

September 2023

Department of Biochemistry and Molecular Biology, College of Basic Medicine, Hebei University of Chinese Medicine, Shijiazhuang, Hebei, China.

NUMB has been initially identified as a critical cell fate determinant that modulates cell differentiation via asymmetrical partitioning during mitosis, including tumor cells. However, it remains absent that a systematic assessment of the mechanisms underlying NUMB and its homologous protein NUMBLIKE (NUMBL) involvement in cancer. This study aimed to investigate the prognostic significance for NUMB and NUMBL in pan-cancer.

View Article and Find Full Text PDF

Here, we investigated mechanisms by which aging-related reductions of the levels of Numb in skeletal muscle fibers contribute to loss of muscle strength and power, two critical features of sarcopenia. Numb is an adaptor protein best known for its critical roles in development including asymmetric cell division, cell-type specification and termination of intracellular signaling. Numb expression is reduced in old humans and mice.

View Article and Find Full Text PDF

Multisystem inflammatory syndrome in children (MIS-C) evolves in some pediatric patients following acute infection with SARS-CoV-2 by hitherto unknown mechanisms. Whereas acute-COVID-19 severity and outcomes were previously correlated with Notch4 expression on Tregs, here, we show that Tregs in MIS-C were destabilized through a Notch1-dependent mechanism. Genetic analysis revealed that patients with MIS-C had enrichment of rare deleterious variants affecting inflammation and autoimmunity pathways, including dominant-negative mutations in the Notch1 regulators NUMB and NUMBL leading to Notch1 upregulation.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!